|Issuer:||RECRO PHARMA, INC. (REPH)|
|Original Submission Date:|
PARKS LAURA L.
C/O RECRO PHARMA, INC.
1 E. UWCHLAN AVE, SUITE 112 EXTON, PA 19341
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||2.23||2021-06-14||deemed execution date||A||20,000 (a)||2031-06-14||common stock 20,000||$2.23||20,000||direct|
|f1||the option will vest in three equal annual installments, beginning on june 14, 2022, subject to the reporting person's continuous service with the company.|